The US FDA study is intended to evaluate the system for treating life-threatening ventricular tachyarrhythmias.

The US Food and Drug Administration has approved Medtronic's novel "extravascular" implantable cardioverter-defibrillator (Aurora EV-ICD) system, which uses a single lead implanted substernally to ...

First-of-its-kind Aurora EV-ICD™ system offers single device, single procedure with lead placed outside of heart and veins FDA approval of the Medtronic Aurora EV-ICD system includes the system's ...

The rate of major complications associated with cardiac implantable electronic-device (CIED) implantation varied widely among different centers in recent data from Australia and New Zealand. The rate ...

DALLAS, March 2, 2010 — A standard test of the implantable cardioverter defibrillator (ICD) is linked to significant thought-processing problems that improve for most patients within a year after the ...

"ICD-11 is in the beta phase right now," Jacobs says. "So we really don't know what it is going to look like when it is finally released in 2015. To say that we'll just forego ICD-10 and go to ICD-11 ...